Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2024; 7(3):e242976. 10.1001/jamanetworkopen.2024.2976

    This cohort study analyzes the association of HSD3B1 status with prostate cancer outcomes among patients in the Veterans Affairs Health System in the US.

  • Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial

    Abstract Full Text
    is active quiz has multimedia
    JAMA. 2024; 331(17):1460-1470. 10.1001/jama.2024.4011

    This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.

  • Predictability of Olfactory Neuroblastoma Staging Systems

    Abstract Full Text
    JAMA Otolaryngol Head Neck Surg. 2023; 150(1):84-85. 10.1001/jamaoto.2023.3634